NCT00195637View on ClinicalTrials.gov

Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

September 16, 2005

Primary Completion Date

July 3, 2006

Study Completion Date

July 3, 2006

Conditions
Hereditary Inclusion Body Myopathy
Interventions
DRUG

Immune Globulin

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Human Genome Research Institute (NHGRI)

NIH

NCT00195637 - Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy | Biotech Hunter | Biotech Hunter